TORONTO — Canada on Monday suspended the use of the Oxford-AstraZeneca coronavirus vaccine for people under age 55 following concerns it might be linked to rare blood clots. The National Advisory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback